Instructions For Authors

Instructions for Authors - Journal of Medicine and Allied Health

If you have any queries regarding preparing your manuscript in compliance with our criteria, the Editorial Office is happy to assist you.

Editorial office: Journal of Medicine and Allied Health
Office, Khan Medical Complex P/O 34400 Pakistan
Tel: +92 316 4638211
Email: info@jomah.org

AIMS AND SCOPE

Journal of Medicine and Allied Health is open access peer reviewed that publishes articles in the fields of Medicine and Allied Health professions including Medicine, Surgery, Pediatrics, Gynecology and Obstetrics, Psychiatry & Neurology, Dermatology, Infectious diseases & Microbiology, Physiotherapy, Metabolic disorders and Biochemistry, Dental hygienic, Dietitian, Nutrition, Physiology, Psychology and Mental Health.

Journal of Medicine and Allied Health publishes original articles, review articles, case reports and correspondences that are of exceptional and unique importance. Research examining innovative medical advancements in clinical, experimental, and allied health disciplines is enthusiastically received. The aim and significance of Journal of Medicine and Allied Health is to provide a forum for the publication of research papers on all aspects of Medicine and Allied Health professions and the exchange of new medical knowledge.

ONLINE SUBMISSION

All manuscripts must be submitted online at: https://login.jomah.org/index.php/ojs/login.

Authors: Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.

Article Publication fees:

While article processing fees are waived, publication fees for local authors amount to 25,000 rupees (approximately) and 100 dollars (for international authors) once the article has been accepted. Waivers may also be granted under specific circumstances.

MANUSCRIPT PREPARATION AND FORMATTING INSTRUCTIONS

Manuscripts must be written in clear, grammatical English. Manuscripts not conforming to Journal format will be returned to authors for modification. Please double space the entire main body document and number each page. Do not add line numbers as the system will generate those when the PDF is built.

Original Research Articles should include the sections listed below:

  • Title Page
  • Abstract
  • Introduction
  • Methods
  • Results
  • Discussion (with or without a labeled Conclusion)
  • Acknowledgments, statement of authors’ contributions to manuscript, and data sharing plan
  • References

Title Page

The title page must include:

  • Title of the article: Clearly and concisely describe the contents of the paper, including animals, participants, or cells studied.
  • Names of all authors: First name, middle initial, last name.
  • Author Affiliations: Departmental and institutional affiliations at the time the research was done.
  • Disclaimers, if any
  • Sources of support for the work: Include sponsor names along with explanations of their role in study design, data collection, analysis, interpretation, and publication. State any restrictions regarding publication.
  • Conflict of Interest and Funding Disclosure: List any financial arrangements between an author and companies whose products are prominently featured in the manuscript or organizations sponsoring the research. If there are no conflicts of interest, list the author’s name followed by “no conflicts of interest.”
  • Corresponding Author’s: Name, mailing address, telephone number, and e-mail address.
  • Running Title: A short title of 50 or fewer characters and spaces.
  • An alphabetized list of abbreviations and their definitions: For all non-standard abbreviations used in the text if there are 3 or more.

Abstract

A properly constructed and informative abstract is helpful for the initial editorial review of the submitted manuscript. Original research articles must include a structured abstract that contains no more than 350 words, written in complete sentences, and includes the following headings:

  • Background: Provide 1 or 2 sentences that explain the context of the study. State the precise objective, the specific hypothesis to be tested, or both.
  • Material and Methods: Describe the study design, including the use of cells, animal models, or human subjects. Identify the control group. Identify specific methods, procedures, and if appropriate, statistical analysis used. Describe interventions, if used.
  • Results: Report the most important findings, including results of statistical analyses.
  • Conclusions: Summarize in 1 or 2 sentences the primary outcomes of the study, including their potential clinical importance, if relevant (avoid generalizations). Include the participants, animals, or cells studied.
  • Clinical Trial Registry (if applicable): Number and website.
  • Registry and registry number for systematic reviews or meta-analyses (if applicable): Provide appropriate registry details.
  • Statement of Significance (Advances only): Add a 1-2 sentence statement explicitly indicating what is truly new in the present work compared to previously published work in the field.

Review articles, special articles, and reports should include an unstructured abstract (no more than 250 words) that states the purpose of the article and emphasizes major concepts and conclusions. Define any abbreviations used in the abstract at first mention.

Keywords: Below the abstract, provide 5–10 keywords or short phrases to increase discoverability. Include terms fundamental to your manuscript but not in the title or abstract. During submission, you will be asked to supply keywords for reviewer searches, which may differ from your list of keywords for publication.

Introduction

Describe clearly the background to the research conducted and the specific objectives. State the specific objective or hypothesis of the study. Do not include methods, data, results, or conclusions from the work being reported.

Materials and Methods

Documentation of methods and materials used should be sufficient to permit replication of the research. Describe clearly the experimental design including the control and experimental groups and provide eligibility and exclusion criteria and details of randomization. Define all group designations parenthetically at first mention (for example, “control (CON) and high-fat (HF) groups”) and include definitions for these abbreviations in the abbreviation footnote on the title page. Describe the methods for, and success of, any masking (blinding) of observations. Report any complications of experimental treatments.

State the product name and manufacturer of specialized materials, diets, chemicals, and instruments and other equipment, where appropriate. Specify kits, analyzers, and commercial laboratories used. Identify precisely all drugs and chemicals used, including generic names, dosages, and routes of administration. If trade names for drugs and chemicals are included, give the manufacturer’s name and location. Do not use trademark names, such as Teflon, as generic terms. Give references for established methods, including statistical methods; provide references and brief descriptions of methods that have been published but are not well known; and describe new or substantially modified methods, giving reasons for using them and evaluating their limitations.

Animal Diets: Composition of control and experimental diets must be presented. When a diet composition is published for the first time in the journal, provide complete information on all components in a table. If previously described in the journal, a reference may be cited. State specifically any modifications made to the published diet compositions. The proximate composition of closed formula diets should be given as amounts of energy, protein, fat, carbohydrate, and fiber. For diets varying in energy density, include percent energy contributions from protein, fat, and carbohydrate. Vitamin and mineral mixture compositions should be included using units and nomenclature as described below. For discussion of the formulation of purified animal diets, refer to the following publications.

The experimental diets should differ from the control diets only in the nutrient(s) being investigated. No purified diets generally should not be used as control diets in rodent species; rodents fed these diets generally should be included for reference only and their data should not be included in the statistical analysis.

Results

Present your results in a logical sequence in the text, tables, and figures. Do not present specifics of data more than once and do not duplicate data from tables or figures in the text. Do not present data from individual subjects except for very compelling reasons. Report losses to observation (such as dropouts from a clinical trial). Use boldface for the first mention of each table or figure.

Discussion

Emphasize concisely the important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or Results. Include the implications of the findings and their limitations and relate the observations to other relevant studies. Link conclusions with the goals of the study and avoid unqualified statements and conclusions that are not completely supported by the data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses and recommendations when warranted by the results and label them clearly as such.

Acknowledgements

Acknowledge only persons who have made substantive contributions to the study. Technical assistance and advice may be acknowledged. Include only named individuals in this section.

Statement of authors’ contributions to manuscript: Authors must indicate their contribution(s) to the manuscript in the Acknowledgments section. Use the relevant descriptors listed below unless the author performed a function that is not covered by one of these. All manuscripts, including reviews, must indicate who is responsible for design, writing, and final content and must include a statement affirming that all authors have read and approved the manuscript. The initials of all authors must be included.

  • Designed research (project conception, development of overall research plan, and study oversight).
  • Conducted research (hands-on conduct of the experiments and data collection).
  • Provided essential reagents or provided essential materials (applies to authors who contributed by providing animals, constructs, databases, etc., necessary for the research).
  • Analyzed data or performed statistical analysis.
  • Wrote paper (only authors who made a major contribution).
  • Had primary responsibility for final content.
  • Other (use only if categories above are not applicable; describe briefly).

All authors have read and approved the final manuscript. For single-authored research papers and reviews, please state: The sole author had responsibility for all parts of the manuscript.

References

The journal uses American Medical Association (AMA) style. References should begin on a separate page and numbered in the order in which they are cited in the text, where they are designated by superscript numbers placed outside periods and commas, and inside colons and semicolons. Only published works and manuscripts that have been accepted for publication should be listed in the References. Manuscripts in preparation, unpublished observations, and personal communications should be referred to in parentheses in the text. Completed manuscripts submitted for publication may be cited as footnotes to the text (see above, Footnotes). If these are subsequently accepted, the author may transfer them to the reference section in galley proof.

References Format: No more than six authors should be listed. If there are seven or more, only the first three followed by ‘‘et al.’’ should be included. Titles of journal articles must be included, and abbreviation of journal names should conform to Index Medicus style.

For information on AMA style, please visit http://www.amamanualofstyle.com.

Tables

Photographs of tables are not acceptable. Type each table, double-spaced throughout (including column headings, footnotes, and data), on a separate page. Tables may be included as part of the Main Body file and placed after the References section. Number the tables in sequence in Arabic numerals and supply a concise, informative title for each one. Each column in the tables should carry a concise heading describing the data in the column. Use lowercase superscript letters to designate footnotes, and type the footnotes below the tables to which they refer. Tables are cited in the text in numerical order. Each table should be able to be understood without consulting the text.

Like text, tables should be prepared using a standard word-processing program and may be included within the main body text document or uploaded separately. Do not upload table files more than once (that is, in the main document and in separate files).

Acceptable document file types for tables include .DOC and .DOCX; do not submit PDF, XLS or XLSX type files.

Figures and Legends

Figures should be uploaded in the highest resolution available. Legends should be supplied for all figures. They are numbered to correspond with the figures and typed double-spaced on a separate page. Figure legends for any supplemental figures being submitted are to be provided separately; see section, Supplemental Digital Content (SDC).

AUTHORSHIP

Journal of Medicine and Allied Health expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.

Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author’s specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:

  • Participated in research design
  • Participated in the writing or critical revision of the paper
  • Participated in the performance of the research
  • Contributed new reagents or analytic tools
  • Participated in data analysis

An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.

AI Announcement

Authors are fully responsible for the content of their manuscript, even those parts produced by GenAI. Authors who have used GenAI in their research and the writing of manuscripts should provide an open, transparent, and detailed description of the use of GenAI (including the name and version of the GenAI tool, when it was used, how it was used, and the process of using it, and, if necessary, annotations for AI-assisted contents dealing with facts and opinions), and review of GenAI, following the body of the text, before the references, or in the method section (e.g., the authors have reviewed and edited the GenAI-produced content, and take full responsibility for the authenticity and accuracy of the content of this paper). It is recommended that authors submit and archive the GenAI-assisted sections (text, figures, programs, etc.) as supplementary material so that reviewers and editors can judge the accuracy, integrity, and originality of the paper.

Since GenAI cannot meet the requirements for authorship as they cannot take responsibility for the submitted work, GenAI-related products and developing teams cannot be listed as the author of a paper.

GenAI cannot be used to write an entire paper or a significant portion of a paper (e.g., method, result and analysis, etc.). All content that falls under the category of scientific contribution or intellectual labor should be finished by the author. If the main content of the paper is completed using GenAI, the editorial office will handle it as academic misconduct.

Plagiarism

As defined by the World Association of Medical Editors (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals), Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).

All allegations of plagiarism are investigated in accordance with the Committee on Publication Ethics (COPE) guidelines detailed at Link. When plagiarism is detected at any time before or after publication, the journal editorial office will take appropriate action as directed by the standards set forth by COPE. If plagiarism is found, the author, the author's institution and funding agencies, and the original publication will be notified. A statement noting the plagiarism, providing a reference to the plagiarized material, and linking to the original paper may follow. Depending on the extent of the plagiarism, the paper may also be formally retracted. For additional information, please visit http://www.publicationethics.org.

JOURNAL POLICIES

Duplicate Publication: Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Journal of Medicine and Allied Health and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in Journal of Medicine and Allied Health to plagiarism-detection software.

This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.

Journal of Medicine and Allied Health publishes original articles, review articles, case reports and correspondences that are of exceptional and unique importance. Most of the time, cross-sectional studies are discouraged unless they are sufficiently shown to be worthwhile.

Disclosure of Conflicts

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript.

All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest” and “Source of Funding”.

For example: “Conflicts of Interest: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared.”

“Source of Funding”: list all the grant supports/funders for the study.

A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.

The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: http://www.icmje.org/conflicts-of-interest.

Studies in Humans and Animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Authors describing studies involving animals must have consulted the ‘Animal Research: Reporting In Vivo Experiments’ (ARRIVE) 2.0 guidelines, developed by the NC3Rs to improve standards of reporting, ensuring that the data from animal experiments can be fully scrutinized and utilized. Articles reporting in vivo experiments must adhere to the ARRIVE Essential 10 checklist as a minimum, and we encourage authors to use the full ARRIVE 2.0 checklist. The relevant information outlined in these guidelines should be included in the appropriate section of the article. All animal experiments should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.

Ethics

When reporting studies on human subjects, author should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). For prospective studies involving human participants, authors are expected to mention about approval of regional/national/institutional or independent ethics committee or review board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed.

Evidence for approval by a local ethics committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving experimental animals and human beings, respectively. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the “Methods” section.

We reserve the right to decline publication of a paper even after it has been accepted if it becomes apparent that there are serious problems with the scientific content or violations of our publishing policies.

Protection of Patients’ Rights to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives written informed consent for publication. Authors should remove patients’ names from figures unless they have obtained written informed consent from the patients. The journal abides by ICMJE guidelines: (1) Authors, not the journals nor the publisher, need to have the patient consent form before the publication related to patient privacy and have the form properly archived by the author. (2) If the publication includes some facial images that make the patients identifiable, a statement about the patient’s consent needs to be present in the manuscript.

ENGLISH EDITING CERTIFICATE

Appropriate use of the English language is a requirement for publication in Journal of Medicine and Allied Health.

For manuscripts submitted by non-native speakers of English, the authors are required to attach the English Editing Certificate. Or acknowledgements at the end the text, which includes the name and institution of English proofreader.

ENGLISH LANGUAGE ASSISTANCE

Appropriate use of the English language is a requirement for publication in Journal of Medicine and Allied Health. Authors who have difficulty in writing in English who submit manuscripts to international journals often receive negative comments from referees or editors about the English-language usage in their manuscripts, and these challenges can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors consider using JOMAH Author Services. (See above our Language Editing Service)

PEER REVIEW

Journal of Medicine and Allied Health operates a double-blind external peer review process, wherein the reviewers and authors are unaware of each other’s identity. Brief introduction on editorial review process of the journal:

On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the readers of the journal are also liable to be rejected at this stage.

Manuscripts that are found suitable for potential publication of the journal are sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. Authors submitting manuscripts to Journal of Medicine and Allied Health may propose suitable reviewers or oppose reviewers who may have competing interests. The proposed reviewers should not be affiliated with the same institutes as the contributor(s). However, the selection of these reviewers is at the sole discretion of the editor, who selects reviewers to reflect relevant expertise, diversity, and geographical backgrounds.

Peer Review Process

Peer reviewers have access to the submitted manuscript and any appendices included by the authors. If the paper is a randomized controlled trial, peer reviewers will also have access to the trial protocol. Peer review assists editors in their decision on whether to publish an article and helps authors revise and improve their manuscripts. Peer reviewers make suggestions for improvements, critique the analysis, point out relevant published work which is not yet cited, and provide recommendations to the authors and the editors. At Journal of Medicine and Allied Health, reviewers are not aware of authors’ identities, meantime, reviewers’ comments are sent to the authors anonymously. Details of peer review including dates and peer review comments are not shared publicly. Reviewed articles are treated confidentially prior to their publication.

Based on the comments from the reviewers, the handling editor takes an acceptance decision on the manuscript and convey the comments and suggestions (acceptance/ rejection/ amendments in manuscript) to the corresponding author, who is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until reviewers and editors are satisfied with the manuscript. Manuscripts are accepted on the basis of quality, originality, significance, novelty, and importance for the field.

Manuscripts received from Editorial Board Members will be screened by the Editor-in-Chief and sent to external peer reviewers. The Editorial Board Members, who submit manuscripts to the journal as authors or co-authors, will be excluded from publication decisions.

Manuscripts received from Editor-in-Chief will be handled by the other co-Editor-in-Chief or one of the Associate Editor of the journal and will be sent to external peer reviewers. The contributing Editor-in-Chief will be excluded from decision-making of his/her manuscript.

Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or whoever relate to products or services in which the editor has an interest. Any such submission is subject to the journal’s standard procedures, with peer review handled independently of the relevant editor and their research groups.

Appeal

The authors have the right to appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal against the editorial decision, they should email the editorial office (email: editoric@jomah.org) explaining in detail the reason for the appeal. The appeals will be acknowledged by the editorial office and will be investigated in an unbiased manner. The processing of appeals will be done within 6–8 weeks. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor-in-Chief of the journal. Second appeals are not considered.

Manuscript Types

  • Original articles: Full-length reports of completed basic, translational, or clinical research. Articles should report important, novel and fully completed studies with strong conclusions. There is also no clear limit on the length of the submitted paper, but authors are encouraged to be concise and concise, preferably within 3,000 words. Articles have a structured abstract of maximum 250 words, including Background, Materials and Methods, Results and Conclusions. The number of references is not limited.
  • Review: Rigorous, balanced reviews on topics of interest to the field. All review articles undergo the same peer-review and editorial process as original research reports.
  • Perspective: Articles that advance a particular viewpoint, acknowledging alternate views, and defending views with published literature to the extent possible.
  • Case reports: New, interesting and rare cases, providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1,000 words (excluding Abstract and references) and should have specific components based on the reporting guidelines (CARE).
  • Correspondences: Information of high interest to the community or comments on papers published in the journal within the previous 6 months. Correspondences may be sent for peer review.
  • Other: Editorial, Guest Editorial, Commentary, and Opinion articles are solicited by the editorial board.

Reporting of Randomized Clinical Trials

Registration of Clinical Trials is an essential requirement for publication of clinical trials in Journal of Medicine and Allied Health. On the title page of your manuscript, provide the name of the trial registry and the registration number/identifier of the trial.

Reports of randomized clinical trials should follow the recommendations given in the Consolidated Standards of Reported Trials (CONSORT) statement http://www.consort-statement.org. In brief, this statement comprises a checklist and flow diagram to help improve the quality of reports of randomized controlled trials and offers a standard way for researchers to report trials.

Optional Reporting Guidelines

The following resources may be helpful to authors:

Financial Support and Competing Interests

A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript. The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: http://www.icmje.org/conflicts-of-interest.

Online Manuscript Submission

New Submissions

Once the manuscript has been created, visit the submission site at https://login.jomah.org/index.php/ojs/login to upload the manuscript. Once the manuscript has been vetted for compliance to the Journal’s requirements, a manuscript number will be assigned to the submission. Failure to adhere to these guidelines will result in your manuscript being returned to you for correction. Faxed, scanned, or emailed copies of manuscripts will not be accepted.

Post Acceptance

Page Proofs

The publisher’s Journal Production Editor will contact you when page proofs are ready for your review. The figures included on author’s proofs are high resolution. Please inform the Journal Production Editor immediately if you have any questions concerning the quality of the figures on the proofs. For information regarding proofs, or the status of publication of your accepted manuscript, please contact the editorial office here: edito@jomah.org.

Copyright

Journal of Medicine and Allied Health is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of Journal of Medicine and Allied Health and may not be published elsewhere without written permission. Journal of Medicine and Allied Health keeps the right to use these manuscripts in any form, including print, video, audio and digital.

Open Access

Every peer-reviewed research article appearing in Journal of Medicine and Allied Health will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. Journal of Medicine and Allied Health charges 25000 PKR from local authors and 100$ from international author for submission, processing or publication of manuscripts and for color reproduction of photographs. Editorial office of Journal of Medicine and Allied Health will make the article open access. This license is the most restrictive of the six main licenses, only allowing others to download your works and share it with others as long as they credit you, but they can't change the work in any way or use it commercially.

Editorial Office Contacts

The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.

Copyright/Disclaimer Notice • Privacy Policy